Opportunity Information: Apply for CDC RFA PS10 1089
Apply for CDC RFA PS10 1089
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening TB/HIV activities in the Central Asian Republics of Kazakhstan, Kyrgyz, Tajikistan, Turkmenistan, and Uzbekistan under the President s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Apr 23, 2010 and posted on Mar 10, 2010.
- Applicants must submit their applications by Apr 23, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $8,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this funding opportunity are listed below Public nonprofit organizations Private nonprofit organizations For profit organizations Small, minority, women owned business Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized Indian tribal organizations Alaska Native tribal governments Indian tribes Tribal Epidemiology centers Indian tribal organizations State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non U.S.) entity Other (specify) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA PS10-1089) is a PEPFAR-supported cooperative agreement from the Centers for Disease Control and Prevention focused on preventing a larger, intertwined TB and HIV epidemic in Central Asia. The target region includes Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan. The central aim is to strengthen how TB and HIV programs work together so that people who have, or may have, either infection can receive more complete, higher-quality, easier-to-access, and more patient-centered prevention, care, and support services. The emphasis is on building practical, on-the-ground collaboration between the two disease programs, rather than treating them as separate systems.
A major feature of the award is the use of pilot sites. The funded organization is expected to support selected sites that can demonstrate real integration of TB and HIV activities. This includes approaches that reduce the risk of TB/HIV co-infection (for example, better coordination of screening, referral, and preventive services) and approaches that show optimal treatment and care for patients already living with both TB and HIV. The announcement makes a clear boundary around scope: the grantee is not responsible for national scale-up of TB/HIV programming across the region. Instead, the work is intended to prove and refine workable models in representative settings that countries and partners could later use to inform broader adoption.
The pilot sites are expected to reflect different epidemiologic or clinical realities, meaning they should be chosen to represent the kinds of settings actually found across these countries. The announcement notes that pilot coverage may include more than one oblast within each country, which signals an interest in learning how integrated service delivery functions across varied subnational contexts rather than a single showcase facility. Applicants are encouraged to propose work plans spanning as many of the five countries as possible, but final decisions on which countries and which activities will be assigned are made at the time of award. In practical terms, an applicant might propose a regional approach and multi-country readiness, while understanding that the CDC will ultimately define the country mix and exact implementation footprint once the cooperative agreement is issued.
From an administrative standpoint, the opportunity is categorized as discretionary funding and uses a cooperative agreement mechanism, which typically implies substantial involvement and collaboration with the funding agency during implementation (as opposed to a more hands-off grant). The activity category is health, and it is linked to CFDA 93.067 (Global AIDS). Only one award was expected, with an estimated total funding amount of $8,000,000. The award floor and ceiling are both listed as 0, which usually indicates that specific budget parameters may be determined through the application and negotiation process rather than being constrained by a stated minimum or maximum per award in the synopsis.
Eligibility is broad and includes public and private nonprofit organizations, for-profit entities (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal entities and tribal epidemiology centers, and U.S. state and local governments (including U.S. territories and affiliated jurisdictions listed in the announcement). Non-U.S. (non-domestic) entities are also eligible. The announcement also describes the option for a bona fide agent to apply on behalf of a state or local government, with the requirement that applicants claiming this status submit documentation (a letter from the relevant government) as part of the application package.
Key dates in the synopsis show the opportunity posted on March 10, 2010, with an original closing date of May 10, 2010, and a current closing date listed as April 23, 2010. The archive date is May 23, 2010, which indicates this is a historical funding announcement that has since closed. For access issues related to the full announcement, the contact provided is the PGO TIMS grants line at 770-488-2700 with a general email referenced in the synopsis.
Frequently Asked Questions (FAQs)
1) What is CDC RFA PS10-1089?
CDC RFA PS10-1089 is a PEPFAR-supported funding opportunity from the Centers for Disease Control and Prevention (CDC) structured as a cooperative agreement. It focuses on preventing a larger, intertwined tuberculosis (TB) and HIV epidemic in Central Asia by strengthening practical collaboration between TB and HIV programs.
2) What is the main goal of this cooperative agreement?
The central aim is to improve how TB and HIV programs work together so that people who have, or may have, either infection can receive more complete, higher-quality, easier-to-access, and more patient-centered prevention, care, and support services.
3) Which countries are included in the target region?
The target region includes Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan.
4) What does the opportunity mean by integrating TB and HIV programs?
The opportunity emphasizes on-the-ground collaboration between TB and HIV programs rather than treating them as separate systems. Examples mentioned include better coordination of screening, referral, and preventive services, as well as approaches that demonstrate optimal treatment and care for people living with both TB and HIV.
5) What are “pilot sites†and why are they important in this award?
Pilot sites are selected locations where the funded organization is expected to support real integration of TB and HIV activities. The purpose is to demonstrate and refine workable models of integrated service delivery in representative settings.
6) Is the grantee responsible for national scale-up of TB/HIV programming?
No. The announcement draws a clear boundary around scope: the grantee is not responsible for national scale-up across the region. The work is intended to prove and refine workable models that countries and partners could later use to inform broader adoption.
7) What kinds of activities are expected at pilot sites?
The pilot sites are expected to demonstrate integrated TB/HIV activities, including approaches that reduce the risk of TB/HIV co-infection (such as improved coordination of screening, referral, and preventive services) and approaches that show optimal treatment and care for patients already living with both TB and HIV.
8) How should pilot sites be selected across the region?
The announcement indicates pilot sites should reflect different epidemiologic or clinical realities and represent the types of settings found across the five countries. It also notes that pilot coverage may include more than one oblast within each country, signaling interest in learning across varied subnational contexts.
9) Should applicants propose work in all five Central Asian countries?
Applicants are encouraged to propose work plans spanning as many of the five countries as possible. However, final decisions on which countries and which activities will be assigned are made at the time of award.
10) Who makes the final decision about which countries and activities are included?
While an applicant can propose a regional approach and multi-country readiness, the CDC ultimately defines the country mix and exact implementation footprint once the cooperative agreement is issued (at the time of award).
11) What type of funding mechanism is used?
This opportunity uses a cooperative agreement mechanism. Based on the synopsis, that typically implies substantial involvement and collaboration with the funding agency during implementation compared to a more hands-off grant.
12) How is this opportunity categorized?
It is categorized as discretionary funding. The activity category is health, and it is linked to CFDA 93.067 (Global AIDS).
13) How many awards were expected?
Only one award was expected.
14) What was the estimated total funding amount?
The estimated total funding amount listed in the synopsis is $8,000,000.
15) Why are the award floor and ceiling listed as 0?
The award floor and ceiling are both listed as 0, which usually indicates that specific budget parameters may be determined through the application and negotiation process rather than being constrained by a stated minimum or maximum per award in the synopsis.
16) Who is eligible to apply?
Eligibility is broad and includes public and private nonprofit organizations, for-profit entities (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal entities and tribal epidemiology centers, and U.S. state and local governments (including U.S. territories and affiliated jurisdictions listed in the announcement). Non-U.S. (non-domestic) entities are also eligible.
17) Are non-U.S. organizations eligible?
Yes. The synopsis states that non-U.S. (non-domestic) entities are eligible.
18) Can a bona fide agent apply on behalf of a state or local government?
Yes. The announcement describes an option for a bona fide agent to apply on behalf of a state or local government, with the requirement that applicants claiming this status submit documentation as part of the application package.
19) What documentation is required for a bona fide agent application?
Applicants claiming bona fide agent status must submit documentation described as a letter from the relevant government as part of the application package.
20) When was this opportunity posted and when did it close?
The synopsis lists the opportunity as posted on March 10, 2010. It shows an original closing date of May 10, 2010, and a current closing date of April 23, 2010.
21) Is this funding opportunity still open?
No. The archive date is May 23, 2010, which indicates this is a historical funding announcement that has since closed.
22) Who should be contacted for access issues related to the full announcement?
For access issues related to the full announcement, the contact provided is the PGO TIMS grants line at 770-488-2700, with a general email referenced in the synopsis.
Browse more opportunities from the same category: Health
Next opportunity: OJJDP FY 2010 AMBER Alert National Training and Technical Assistance Program
Previous opportunity: Strengthening HIV and Co infection Prevention Activities in Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the President s Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 1089
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 1089) also looked into and applied for these:
| Funding Opportunity |
|---|
| FY10 Promote, Support and Build Capacity in the Medical Reserve Corps Apply for SG MRC 10 001 Funding Number: SG MRC 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,650,000 |
| Strengthening HIV/AIDS Prevention for Most at Risk Populations in Namibia Apply for 674 10 0027 Funding Number: 674 10 0027 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $5,400,000 |
| HIV prevention activities in target communities in Zambia Apply for 611 2010 09AMENDMENT01 Funding Number: 611 2010 09AMENDMENT01 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $4,400,000 |
| Tribal Self Governance Program Negotiation Cooperative Agreement Apply for HHS 2010 IHS TSGN 0001 Funding Number: HHS 2010 IHS TSGN 0001 Agency: Indian Health Service Category: Health Funding Amount: $30,000 |
| Tribal Self Governance Program Planning Cooperative Agreement Apply for HHS 2010 IHS TSGP 0001 Funding Number: HHS 2010 IHS TSGP 0001 Agency: Indian Health Service Category: Health Funding Amount: $75,000 |
| Grants to Expand Substance Abuse Treatment in Targeted Areas of Need Technology Assisted Care Apply for TI 10 012 Funding Number: TI 10 012 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $400,000 |
| ARRA OS Recovery Act Limited Competition Impact of Decision Support Systems on the Dissemination and Adoption of Imaging Related Comparative Effectiveness Findings (UC4) Apply for RFA OD 10 012 Funding Number: RFA OD 10 012 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Rural Training Track Technical Assistance Demonstration Program Apply for HRSA 10 192 Funding Number: HRSA 10 192 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| A Prospective Birth Cohort Study Involving Environmental Uranium Exposure in the Navajo Nation (U01) Apply for RFA TS 10 001 Funding Number: RFA TS 10 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NCZVED, American Red Cross, San Juan Puerto Rico Apply for CDC RFA CK10 006E Funding Number: CDC RFA CK10 006E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Programs for the Prevention of Fire Related Injuries Apply for CE06 60105CONT10 Funding Number: CE06 60105CONT10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NCMHD Advances in Health Disparities Research on Social Determinants of Health (R01) Apply for RFA MD 10 005 Funding Number: RFA MD 10 005 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Development, Implementation, and Evaluation of a Multi Component Intervention to Vaccinate Adolescents at Risk for Vaccine Preventable Diseases (U01) Apply for RFA IP 10 002 Funding Number: RFA IP 10 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Malaria Action Program for States (MAPS) Apply for RFA 620 10 07 Funding Number: RFA 620 10 07 Agency: Agency for International Development Category: Health Funding Amount: $82,000,000 |
| Cooperative Agreement Program for the National Academic Centers of Excellence in Youth Violence Prevention (U01) Apply for CDC PA CE10 004 Funding Number: CDC PA CE10 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,300,000 |
| Rural Health Workforce Development Program Apply for HRSA 10 193 Funding Number: HRSA 10 193 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Evaluation and Impact of a State Law Requiring Mandatory Influenza Vaccination of Hospital Employees (U01) Apply for RFA IP 10 003 Funding Number: RFA IP 10 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| New York HIV/AIDS Education and Prevention, AIDS Community Resources, Inc Apply for CDC RFA PS10 1056E Funding Number: CDC RFA PS10 1056E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| National Program to Eliminate Diabetes Related Disparities in Vulnerable Populations Apply for CDC RFA DP10 1001 Funding Number: CDC RFA DP10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| South Carolina HIV/AIDS Council HIV/AIDS Prevention Program Apply for CDC RFA PS10 10179E Funding Number: CDC RFA PS10 10179E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1089", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.